Clinical role of positron emission tomography in oncology (Q34570065)

3 August 2017

1 reference

title

Clinical role of positron emission tomography in oncology (English)

1 reference

positron emission tomography

3 August 2017

1 reference

J B Bomanji

1

1 reference

PubMed ID

11902566

3 August 2017

D C Costa

series ordinal

2

1 reference

PubMed ID

11902566

3 August 2017

P J Ell

series ordinal

3

1 reference

3 August 2017

1 March 2001

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

3

1 reference

3 August 2017

157-164

1 reference

How Cells Absorb Glucose / Gustav E. Lienhard, Jan W. Slot, David E. James and Mike M. Mueckler. - (1992)

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Metabolic staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Positron emission tomography in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Prospective investigation of positron emission tomography in lung nodules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Surrogate endpoints in assessment of new drugs in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Positron emission tomography and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Positron emission tomography scanning in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Effectiveness of positron emission tomography for the detection of melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

The Role of FDG-PET in the Preoperative Assessment of N-Staging in Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Being equipped for clinical PET

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

Commentary. Are current tumour response criteria relevant for the 21st century?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900257-6

7 January 2021

10.1016/S1470-2045(00)00257-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11902566